Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20184501.
- Also identified by DOI 10.3109/14653241003587652.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Negative-contrast magnetic resonance imaging (MRI) methods utilizing magnetic susceptibility contrast agents have become one of the most widely used approaches in cellular imaging research. However, visualizing and tracking super-paramagnetic iron oxide nanoparticle (SPIO)-labeled cells on the basis of negative-contrast can limit specificity and sensitivity. Therefore, there has been a strong motivation to explore MRI methods for cellular imaging with either positive or dual contrast (both positive and negative) for identifying labeled cells; these methods offer the potential to improve significantly the sensitivity and specificity of MRI-based cell-tracking approaches. In this review, current state-of-the-art positive- and dual-contrast MRI techniques and contrast agents are described specifically for applications involving in vivo cellular tracking and imaging.
Medical subject headings
- Cell Tracking
- Contrast Media
- Ferric Compounds
- Magnetic Resonance Imaging
- Neoplasms